Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

Nutra Pharma Corporation (NPHC)

-Other OTC
0.01 Down 0.00(2.15%) 3:46PM EDT
ProfileGet Profile for:
Nutra Pharma Corporation
12502 West Atlantic Boulevard
Coral Springs, FL 33071
United States - Map
Phone: 954-509-0911
Fax: 877-895-5647

Index Membership:N/A
Full Time Employees:3

Business Summary 

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, as well as homeopathic and ethical drugs for manages pain, neurological disorders, cancer, autoimmune, and infectious diseases. The company, through its subsidiary, ReceptoPharm, carries out homeopathic and drug discovery research and clinical development. It offers Cobroxin and Nyloxin/Nyloxin Extra Strength that are homeopathic over-the-counter drugs to treat moderate to severe chronic pain. The company is also developing RPI-78M to treat neurological diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, and myasthenia gravis; RPI-MN to treat viral diseases, such as HIV/AIDS and Herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. In addition, it develops Pet Pain-Away, a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever to treat severe chronic pain in companion animals; and Equine Nyloxin, a topical therapy for horses. Further, the company seeks strategic licensing partnerships to reduce the risks associated with the drug development process. Nutra Pharma Corp. was founded in 2000 and is headquartered in Coral Springs, Florida.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Nutra Pharma Corporation

Key Executives 
Mr. Rik J. Deitsch , 46
Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Principal Accounting Officer
Mr. Neil Roth ,
Pres of Designer Diagnostics
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders